cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 1.2%

Shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) fell 1.2% during mid-day trading on Wednesday . The company traded as low as $0.46 and last traded at $0.47. 25,639 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 183,599 shares. The stock had previously closed at $0.48.

cbdMD Price Performance

The stock has a market capitalization of $1.84 million, a price-to-earnings ratio of -0.04 and a beta of 2.01. The company has a quick ratio of 0.61, a current ratio of 1.07 and a debt-to-equity ratio of 0.88.

cbdMD (NYSEAMERICAN:YCBD) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($1.35) earnings per share (EPS) for the quarter. cbdMD had a negative return on equity of 193.04% and a negative net margin of 102.25%. The firm had revenue of $4.82 million for the quarter.

Institutional Trading of cbdMD

An institutional investor recently raised its position in cbdMD stock. AXS Investments LLC raised its position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) by 42.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 91,204 shares of the company’s stock after purchasing an additional 27,017 shares during the quarter. AXS Investments LLC owned 2.99% of cbdMD worth $95,000 at the end of the most recent quarter. Institutional investors own 7.18% of the company’s stock.

About cbdMD

cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.